Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 950 of 5804
-
Eye drops could replace needle injections for wet AMD
Disease control Not yet recruitingTrial to Evaluate the Safety and Efficacy of SCAI-005 Ophthalmic solution in Patients with Neovascular Age-related Macular Degeneration. The purpose of this study is to investigate the efficacy, safety and tolerability of SCAI-005 Ophthalmic solution by dose in patients with neo…
Phase: PHASE2 • Sponsor: SCAI Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
CAR-T breakthroughs come with infection risks – new study aims to decode them
Knowledge-focused Not yet recruitingThis study includes adults with multiple myeloma or B-cell lymphoma who were/will be treated with CAR-T cell therapy at the IRCCS Azienda Ospedaliero-Universitaria di Bologna. The aim is to better understand infections that may occur during the first year after CAR-T treatment, i…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New PET tracer may reveal which bile duct cancers resist standard therapy
Diagnosis Not yet recruitingThis phase II trial studies whether \[18F\]FTT can be used with positron emission tomography (PET)/computed tomography (CT) imaging to predict treatment response in patients scheduled to receive gemcitabine, cisplatin, and durvalumab (GCD) for newly diagnosed cholangiocarcinoma. …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Keyhole surgery may beat standard care for chest infections
Disease control Not yet recruitingThe PROMPT study is testing whether an early keyhole procedure called Medical Thoracoscopy, which lets doctors look inside the chest and remove infected fluid, works better than current standard treatment (medicines to break up thick fluid) for people with pleural infection. Abou…
Phase: NA • Sponsor: Università Politecnica delle Marche • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug hope for rare throat and thyroid cancers
Disease control Not yet recruitingThis is an open-label, investigator-initiated phase II clinical trial designed to evaluate the efficacy and safety of Sacituzumab Tirumotecan (sac-TMT) monotherapy in patients with recurrent or metastatic adenoid cystic carcinoma (ACC) of salivary gland origin and papillary thyro…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Virtual bees and wasps may alter allergy immune responses — a trial puts it to the test
Knowledge-focused Not yet recruitingThis study investigates whether immersive virtual reality (VR) exposure to allergen-related stimuli can modulate behavioural, neurophysiological, psychophysiological, and immune responses in adults with bee or wasp venom allergy. The study consists of two parts. In Part 1, adult…
Phase: NA • Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Brain pacemaker targets seizures in Drug-Resistant epilepsy
Disease control Not yet recruitingThis self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centromedian (CM) thalamus deep brain stimulation (DBS) for drug resistant epilepsy with motor symptom in adults.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Brain zaps aim to restore walking after spinal injury
Symptom relief Recruiting nowThis is a study about deep brain stimulation (DBS) as an investigational treatment for walking impairment following spinal cord injury (SCI). The purpose of this study is to assess the feasibility and inform on the safety, and efficacy of CnF DBS to improve gait in SCI patients w…
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could a drug calm the immune storm in severe abdominal infections?
Disease control Not yet recruitingComplicated intra-abdominal infection (cIAI) triggers dysregulated systemic inflammation and immune paralysis leading to high organ failure and death risk. Ulinastatin is a protease inhibitor with anti-inflammatory properties, but its dose-related effects on immune-inflammation o…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New antibody ABBV-383 takes on Hard-to-Treat blood cancer
Disease control Not yet recruitingThis phase I/II trial studies the side effects and best dose of ABBV-383 and to see how well it works in treating patients with Waldenström macroglobulinemia that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). ABBV-383 i…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New PAH drug IKT-001 moves to Long-Term safety check
Disease control Not yet recruitingThis is a multicenter, open-label extension (OLE), single-arm study designed to assess the long-term safety and tolerability of oral IKT-001 administered once daily.
Phase: PHASE3 • Sponsor: Inhibikase Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Drone Warfare's hidden toll: new study tracks infection risk in combat wounds
Knowledge-focused Not yet recruitingDrone-related combat injuries have become one of the most devastating mechanisms of injury in modern warfare. These injuries often cause extensive tissue devitalization, contamination, open fractures, vascular injuries, and complex soft tissue damage, which may substantially incr…
Sponsor: Ukrainian Society of Regional Anesthesia and Pain Therapy • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Could a VR AI agent beat a chatbot for treating insomnia?
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a virtually embodied artificial intelligence (AI) agent delivered via VR-enhanced digital cognitive behavioral therapy for insomnia (dCBT-I) can improve insomnia outcomes and treatment adherence in adults with insomnia. The …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Stem cell patch aims to mend broken hearts in landmark trial
Disease control Not yet recruitingThis is an exploratory study. A total of 16 patients meeting the inclusion and exclusion criteria and awaiting coronary artery bypass grafting (CABG) surgery will be enrolled. After providing informed consent, participants will be randomized 1:1 under double-blind conditions into…
Phase: PHASE1, PHASE2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New insulin tech aims to improve blood sugar control in type 1 diabetes
Disease control Not yet recruitingThe purpose of the study is to evaluate the safety and the effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery system, named MiniMed NMX8 system (referred also to as NMX8 system), in comparison with other commercially available AID systems (Automated insu…
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a cocktail of leucine, sildenafil, and metformin tame hypertension?
Disease control Not yet recruitingThis 12-week, randomized, double-blind, placebo-controlled Phase 2 study will evaluate two fixed-dose oral combinations of L-leucine, sildenafil, and metformin (NS-0200) versus matching placebo in adults 18-75 years with hypertension. Approximately 150 subjects will be screened t…
Phase: PHASE2 • Sponsor: NuSirt Biopharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets tough lymphomas in early trial
Disease control Recruiting nowThis phase Ib/II trial tests the safety, side effects, best dose and how well giving CX-5461 works for the treatment of patients with B-cell non-Hodgkin lymphoma. CX-5461 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving CX-5461 ma…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Village women trained as mentors to help others take charge of birth control decisions
Disease control Not yet recruitingThis is a cluster-randomized controlled trial to determine the effectiveness of the community-based "I-CAN" intervention to improve agency in contraceptive decision-making and use in rural Uganda. Lay women will be trained to serve as peer mentors to other women of reproductive a…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
Disease control Not yet recruitingThis clinical trial identifies the needs and preferences of rural stage I-III postmenopausal breast and endometrial cancer survivors and evaluates the impact of an adaptive, online program, mobile (m)Health + ecological momentary assessment (EMA) intervention, on lifestyle modifi…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug imetelstat targets rare blood cancer in phase 2 trial
Disease control Not yet recruitingTo learn if imetelstat can help to control MDS/MPNs.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC